'Neuro'-peptides in glia: Focus on NPY and galanin

Trends in Neurosciences

Volumn 26, Issue 11, 2003, Pages 604-609

  Ubink, Ruud ^a,c   Calza, Laura ^b   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; NEUROPEPTIDE Y;

ASTROCYTE; GLIA; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHWANN CELL;

EID: 0242317366     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2003.09.003     Document Type: Review

References (75)

1. Kettenmann H., Ransom B.R. Neuroglia. 1995;Oxford University Press.
2. de Wied D., Burbach J.P.H. Neuropeptides and behaviour. Adelman G., Smith B.H. Encyclopedia of Neuroscience. Vol. 2:1999;1431-1436 Elsevier.
3. Martin D.L. Synthesis and release of neuroactive substances by glial cells. Glia. 5:1992;81-94.
4. McMillian M.K., Hong J.S. Regulation of preproenkephalin expression in astrocytes: is there a role for glia-derived opioid peptides in reactive gliosis? Crit. Rev. Neurobiol. 9:1994;91-103.
5. Schwartz J.P., Taniwaki T. Heterogeneity of expression of neuropeptide genes by astrocytes: functional implications. Perspect. Dev. Neurobiol. 2:1994;251-257.
6. Muller H.W., et al. Astroglial neurotrophic and neurite-promoting factors. Pharmacol. Ther. 65:1995;1-18.
7. Eddleston M., Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
8. Hösli E., Hösli L. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog. Neurobiol. 40:1993;477-506.
9. Kimelberg H.K. Receptors on astrocytes - what possible functions? Neurochem. Int. 26:1995;27-40.
10. Wilkin G.P., et al. Peptide receptors on astrocytes. Kettenmann H., Ransom B.R. Neuroglia. 1995;367-376 Oxford University Press.
11. Deschepper C.F. Peptide receptors on astrocytes. Front. Neuroendocrinol. 19:1998;20-46.
12. Stornetta R.L., et al. Astrocytes synthesize angiotensinogen in brain. Science. 242:1988;1444-1446.
13. Intebi A.D., et al. Angiotensinogen production by rat astroglial cells in vitro and in vivo. Neuroscience. 34:1990;545-554.
14. Bunnemann B., et al. The semi-quantitative distribution and cellular localization of angiotensinogen mRNA in the rat brain. J. Chem. Neuroanat. 5:1992;245-262.
15. McKenzie J.C. Atrial natriuretic peptide-like immunoreactivity in astrocytes of parenchyma and glia limitans of the canine brain. J. Histochem. Cytochem. 40:1992;1211-1222.
16. McKenzie J.C., et al. Atrial natriuretic peptide-like (ANP-LIR) and ANP prohormone immunoreactive astrocytes and neurons of human cerebral cortex. Glia. 12:1994;228-243.
17. McKenzie J.C., et al. Atrial natriuretic peptide-like immunoreactivity in neurons and astrocytes of human cerebellum and inferior olivary complex. J. Histochem. Cytochem. 49:2001;1453-1467.
18. Bonfanti L., et al. Carnosine-related dipeptides in the mammalian brain. Prog. Neurobiol. 59:1999;333-353.
19. Vilijn M.H., et al. Expression of preproenkephalin mRNA by cultured astrocytes and neurons. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6551-6555.
20. Shinoda H., et al. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science. 245:1989;415-417.
21. Shinoda H., et al. Developmental expression of the proenkephalin and prosomatostatin genes in cultured cortical and cerebellar astrocytes. Dev. Brain Res. 67:1992;205-210.
22. Hauser K.F., et al. Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes. Brain Res. 522:1990;347-353.
23. Melner M.H., et al. The regulation of proenkephalin expression in a distinct population of glial cells. EMBO J. 9:1990;791-796.
24. Schafer M.K., et al. Proenkephalin messenger RNA is expressed both in the rat anterior and posterior pituitary. Neuroendocrinology. 51:1990;444-448.
25. Just L., et al. Glial expression of the proenkephalin gene in slice cultures of the subventricular zone. J. Mol. Neurosci. 11:1998;57-66.
26. Knapp P.E., et al. Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development. Glia. 35:2001;156-165.
27. Xu Z., et al. Evidence for upregulation of galanin synthesis in rat glial cells in vivo after colchicine treatment. Neurosci. Lett. 145:1992;185-188.
28. Shen, P.J. et al. (2002) Galanin expression by oligodendroglial progenitors: novel role(s) for a neuropeptide? Program No. 448.7. 2002 Abstract Viewer and Itinerary Planner, Society for Neuroscience, CD-Rom.
29. Barnea A., et al. Evidence for regulated expression of neuropeptide Y gene by rat and human cultured astrocytes. Regul. Pept. 75-76:1998;293-300.
30. Barnea A., et al. Interleukin-1β induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes. Brain Res. 896:2001;137-145.
31. Ubink R., et al. Neuropeptide tyrosine is expressed in ensheathing cells around the olfactory nerves in the rat olfactory bulb. Neuroscience. 60:1994;709-726.
32. Ubink R., Hökfelt T. Expression of neuropeptide Y in olfactory ensheathing cells during prenatal development. J. Comp. Neurol. 423:2000;13-25.
33. Au W.W., et al. Sublaminar organization of the mouse olfactory bulb nerve layer. J. Comp. Neurol. 446:2002;68-80.
34. Ubink R., Hökfelt T. Neuropeptide Y expression in Schwann cell precursors. Glia. 32:2000;71-83.
35. Buzas B. Regulation of nociceptin/orphanin FQ gene expression in astrocytes by ceramide. Neuroreport. 13:2002;1707-1710.
36. Boersma C.J., et al. Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe. Brain Res. 611:1993;117-129.
37. Janaky T., et al. Identification of oxytocin and vasopressin from neurohypophyseal cell culture. Rapid Commun. Mass Spectrom. 12:1998;1765-1768.
38. Chronwall B.M., et al. Glial somatostatin-14 expression in the rat pituitary intermediate lobe: a possible neurotrophic function during development? Int. J. Dev. Neurosci. 18:2000;685-692.
39. Too H.P., et al. Preprotachykinin-A and substance P receptor (NK1) gene expression in rat astrocytes in vitro. Neurosci. Lett. 182:1994;185-187.
40. Lai J.P., et al. Detection of substance P and its receptor in human fetal microglia. Neuroscience. 101:2000;1137-1144.
41. Paspalas C.D., et al. Vasoactive intestinal polypeptide in neuroglia? Immunoelectron microscopic localization in astrocytes of the rat mesencephalon. Glia. 34:2001;229-233.
42. Virgintino D., et al. Vasoactive intestinal polypeptide-like immunoreactivity in astrocytes of the human brain. Neuroreport. 7:1996;1577-1581.
43. Gajkowska B., Viron A. Ultrastructural evidence for endogenous vasoactive intestine peptide-like immunoreactivity in neurohypophysis. Neuroendocrinol. Lett. 13:1990;389-391.
44. Polazzi E., Contestabile A. Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev. Neurosci. 13:2002;221-242.
45. Zagon I.S., McLaughlin P.J. Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res. 412:1987;68-72.
46. Hauser K.F., et al. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J. Comp. Neurol. 281:1989;13-22.
47. Doucette J.R. The glial cells in the nerve fiber layer of the rat olfactory bulb. Anat. Rec. 210:1984;385-391.
48. Doucette R. Glial influences on axonal growth in the primary olfactory system. Glia. 3:1990;433-449.
49. Graziadei P.P.C., Monti Graziadei G.A. Continuous nerve cell renewal in the olfactory system. Jacobsen M. Handbook of Sensory Physiology. Vol. 9:1978;55-82 Springer-Verlag.
50. Mirsky R., Jessen K.R. The neurobiology of Schwann cells. Brain Pathol. 9:1999;293-311.
51. Jessen K.R., Mirsky R. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 22:1999;402-410.
52. Erickson J.C., et al. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421.
53. Mombaerts P., et al. Visualizing an olfactory sensory map. Cell. 87:1996;675-686.
54. Hansel D.E., et al. Neuropeptide Y functions as a neuroproliferative factor. Nature. 410:2001;940-944.
55. White D.M. Contribution of neurotrophin-3 to the neuropeptide Y-induced increase in neurite outgrowth of rat dorsal root ganglion cells. Neuroscience. 86:1998;257-263.
56. Zukowska-Grojec Z., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83:1998;187-195.
57. Raisman G. Olfactory ensheathing cells - another miracle cure for spinal cord injury? Nat. Rev. Neurosci. 2:2001;369-375.
58. Ramon-Cueto A., Santos-Benito F.F. Cell therapy to repair injured spinal cords: olfactory ensheathing glia transplantation. Restor. Neurol. Neurosci. 19:2001;149-156.
59. Calza L., et al. Thyroid hormone-dependent regulation of galanin synthesis in neurons and glial cells after colchicine administration. Neuroendocrinology. 68:1998;428-436.
60. Hooi S.C., et al. Regulation of anterior pituitary galanin gene expression by thyroid hormone. Mol. Brain Res. 51:1997;15-22.
61. Gao F.B., Raff M. Cell size control and a cell-intrinsic maturation program in proliferating oligodendrocyte precursor cells. J. Cell Biol. 138:1997;1367-1377.
62. Durand B., Raff M. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays. 22:2000;64-71.
63. Dawson M.R., et al. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J. Neurosci. Res. 61:2000;471-479.
64. Jones L.L., et al. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22:2002;2792-2803.
65. Levine J.M., et al. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24:2001;39-47.
66. Hökfelt T., et al. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci. Lett. 83:1987;217-220.
67. Kashiba H., et al. Axonal blockade induces the expression of vasoactive intestinal polypeptide and galanin in rat dorsal root ganglion neurons. Brain Res. 577:1992;19-28.
68. Holmes F.E., et al. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11563-11568.
69. Mahoney S.A., et al. The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons. J. Neurosci. 23:2003;416-421.
70. Xu Z.-Q., et al. Expression of galanin and a galanin receptor in several sensory systems and bone anlage of rat embryos. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14901-14905.
71. Tarasov K.V., et al. Galanin and galanin receptors in embryonic stem cells: accidental or essential? Neuropeptides. 36:2002;239-245.
72. Seufferlein T., Rozengurt E. Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res. 56:1996;5758-5764.
73. Berger A., et al. Elevated expression of galanin receptors in childhood neuroblastic tumors. Neuroendocrinology. 75:2002;130-138.
74. Perel Y., et al. Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. Br. J. Cancer. 86:2002;117-122.
75. Krzan M., et al. Calcium-dependent exocytosis of atrial natriuretic peptide from astrocytes. J. Neurosci. 23:2003;1580-1583.